GSK3β promotes apoptosis after renal ischemic injury

Journal of the American Society of Nephrology

Volumn 21, Issue 2, 2010, Pages 284-294

  Wang, Zhiyong ^a   Havasi, Andrea ^a   Gall, Jonathan ^a   Bonegio, Ramon ^a   Li, Zhijian ^b   Mao, Haiping ^b   Schwartz, John H ^a   Borkan, Steven C ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 BENZYL 2 METHYL 1,2,4 THIADIAZOLIDINE 3,5 DIONE; CASPASE 3; CREATININE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN BAX; SERINE; UNCLASSIFIED DRUG; 4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; THIADIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL SURVIVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY DYSFUNCTION; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; MALE; METABOLIC STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RNA INTERFERENCE; ACUTE KIDNEY FAILURE; ANIMAL; CELL LINE; DRUG ANTAGONISM; EPITHELIUM CELL; KIDNEY PROXIMAL TUBULE; METABOLISM; PATHOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE; EPITHELIAL CELLS; GLYCOGEN SYNTHASE KINASE 3; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, PROXIMAL; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA INTERFERENCE; THIADIAZOLES;

EID: 77949392941     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009080828     Document Type: Article

References (72)

1. Ueda N, Shah SV: Tubular cell damage in acute renal failure-apopto-sis, necrosis, or both. Nephrol Dial Transplant 15: 318-323, 2000
2. Bonegio R, Lieberthal W: Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11: 301-308, 2002
3. Lieberthal W, Koh JS, Levine JS: Necrosis and apoptosis in acute renal failure. Semin Nephrol 18: 505-518, 1998
4. Versteilen AM, Di Maggio F, Leemreis JR, Groeneveld AB, Musters RJ, Sipkema P: Molecular mechanisms of acute renal failure following ischemia/reperfusion. Int J Artif Organs 27: 1019-1029, 2004
5. Ortiz A, Justo P, Catalan MP, Sanz AB, Lorz C, Egido J: Apoptotic cell death in renal injury: The rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord 2: 181-192, 2002
6. Sheridan AM, Bonventre JV: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9: 427-434, 2000
7. Vincent JL, Bota DP, De Backer D: Epidemiology and outcome in renal failure. Int J Artif Organs 27: 1013-1018, 2004
8. Basile DP, Liapis H, Hammerman MR: Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. Am J Physiol 272: F640-F647, 1997
9. Schumer M, Colombel MC, Sawczuk IS, Gobe G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R: Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140: 831-838, 1992
10. Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, Endre ZH: Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 11: 454-467, 2000
11. Lieberthal W, Menza SA, Levine JS: Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 274: F315-F327, 1998
12. Wang Y, Knowlton AA, Christensen TG, Shih T, Borkan SC: Prior heat stress inhibits apoptosis in adenosine triphosphate-depleted renal tubular cells. Kidney Int 55: 2224-2235, 1999
13. Frame S, Cohen P: GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359: 1-16, 2001
14. Nelson WJ, Nusse R: Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487, 2004
15. Loberg RD, Vesely E, Brosius FC 3rd: Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J Biol Chem 277: 41667-41673, 2002
16. Ferkey DM, Kimelman D: GSK-3: New thoughts on an old enzyme. Dev Biol 225: 471-479, 2000
17. Grimes CA, Jope RS: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426, 2001
18. Jope RS, Johnson GV: The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29: 95-102, 2004
19. Doble BW, Woodgett JR: GSK-3: Tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186, 2003
20. Farooqui R, Zhu S, Fenteany G: Glycogen synthase kinase-3 acts upstream of ADP-ribosylation factor 6 and Rac1 to regulate epithelial cell migration. Exp Cell Res 312: 1514-1525, 2006
21. Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, Maggirwar SB: Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kap-paB signaling. Mol Cell Biol 23: 4649-4662, 2003
22. Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Monte-sano R, Roskelley C, Grosschedl R, Dedhar S: Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA 95: 4374-4379, 1998
23. Sinha D, Wang Z, Ruchalski KL, Levine JS, Krishnan S, Lieberthal W, Schwartz JH, Borkan SC: Lithium activates the Wnt and phosphatidyl-inositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol 288: F703-F713, 2005
24. Rao R, Hao CM, Breyer MD: Hypertonic stress activates glycogen synthase kinase 3beta-mediated apoptosis of renal medullary interstitial cells, suppressing an NFkappaB-driven cyclooxygenase-2-depen-dent survival pathway. J Biol Chem 279: 3949-3955, 2004
25. Mora A, Sabio G, Risco AM, Cuenda A, Alonso JC, Soler G, Centeno F: Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell Signal 14: 557-562, 2002
26. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ: Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113: 1535-1549, 2004
27. Wang Y, Huang WC, Wang CY, Tsai CC, Chen CL, Chang YT, Kai JI, Lin CF: Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis. Br J Pharmacol 157: 1004-1013, 2009
28. Tong H, Imahashi K, Steenbergen C, Murphy E: Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3- kinase-dependent pathway is cardioprotec-tive. Circ Res 90: 377-379, 2002
29. Kovacs K, Toth A, Deres P, Kalai T, Hideg K, Gallyas F Jr, Sumegi B: Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion. Biochem Pharmacol 71: 441-452, 2006
30. Park SS, Zhao H, Mueller RA, Xu Z: Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol 40: 708-716, 2006
31. Li XL, Man K, Ng KT, Sun CK, Lo CM, Fan ST: The influence of phosphatidylinositol 3-kinase/Akt pathway on the ischemic injury during rat liver graft preservation. Am J Transplant 5: 1264-1275, 2005
32. Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala EM, Louhe-lainen M, Foster SJ, Yaqoob MM, Thiemermann C: GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit Care Med 33: 1903-1912, 2005
33. Obligado SH, Ibraghimov-Beskrovnaya O, Zuk A, Meijer L, Nelson PJ: CDK/GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases. Kidney Int 73: 684-690, 2008
34. Collino M, Thiemermann C, Mastrocola R, Gallicchio M, Benetti E, Miglio G, Castiglia S, Danni O, Murch O, Dianzani C, Aragno M, Fantozzi R: Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Shock 30: 299-307, 2008
35. Nishihara M, Miura T, Miki T, Tanno M, Yano T, Naitoh K, Ohori K, Hotta H, Terashima Y, Shimamoto K: Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocar-dial protection. J Mol Cell Cardiol 43: 564-570, 2007
36. Cuzzocrea S, Mazzon E, Esposito E, Muia C, Abdelrahman M, Di Paola R, Crisafulli C, Bramanti P, Thiemermann C: Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut. Intensive Care Med 33: 880-893, 2007
37. Diehl JA, Cheng M, Roussel MF, Sherr CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511, 1998
38. Maniatis T: A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless and Hedgehog signaling pathways. Genes Dev 13: 505-510, 1999
39. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN: Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4: 327-332, 1993
40. Chiang-Ting C, Tzu-Ching C, Ching-Yi T, Song-Kuen S, Ming-Kuen L: Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/ reperfusion induced tubular oxidative stress and apoptosis. Am J Transplant 5: 1194-1203, 2005
41. Kelly KJ, Sutton TA, Weathered N, Ray N, Caldwell EJ, Plotkin Z, Dagher PC: Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury. Am J Physiol Renal Physiol 287: F760-F766, 2004
42. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML, Heidenreich KA: Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 24: 9993-10002, 2004
43. Jope RS: Lithium and GSK-3: One inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24: 441-443, 2003
44. Plotnikov EY, Kazachenko AV, Vyssokikh MY, Vasileva AK, Tcvirkun DV, Isaev NK, Kirpatovsky VI, Zorov DB: The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney Int 72: 1493-1502, 2007
45. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR: Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabi-lization and apoptosis by destabilization of MCL-1. Mol Cell 21: 749-760, 2006
46. Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borre-gaard N, Marrack P, Bratton DL, Henson PM: Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 279: 21085-21095, 2004
47. del Mar Martinez-Senac M, Corbalan-Garcia S, Gomez-Fernandez JC: Conformation of the C-terminal domain of the pro-apoptotic protein Bax and mutants and its interaction with membranes. Biochemistry 40: 9983-9992, 2001
48. Suzuki M, Youle RJ, Tjandra N: Structure of Bax: Coregulation of dimer formation and intracellular localization. Cell 103: 645-654, 2000
49. Cartron PF, Arokium H, Oliver L, Meflah K, Manon S, Vallette FM: Distinct domains control the addressing and the insertion of Bax into mitochondria. J Biol Chem 280: 10587-10598, 2005
50. Hsu YT, Wolter KG, Youle RJ: Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA 94: 3668-3672, 1997
51. Havasi A, Li Z, Wang Z, Martin JL, Botla V, Ruchalski K, Schwartz JH, Borkan SC: Hsp27 inhibits Bax activation and apoptosis via a phos-phatidylinositol 3-kinase-dependent mechanism. J Biol Chem 283: 12305-12313, 2008
52. Zamzami N, Kroemer G: Apoptosis: Mitochondrial membrane perme-abilization: The (w)hole story? Curr Biol 13: R71-R73, 2003
53. Chipuk JE, Bouchier-Hayes L, Green DR: Mitochondrial outer membrane permeabilization during apoptosis: The innocent bystander scenario. Cell Death Differ 13: 1396-1402, 2006
54. Bellot G, Cartron PF, Er E, Oliver L, Juin P, Armstrong LC, Bornstein P, Mihara K, Manon S, Vallette FM: TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mito-chondrial receptor for the proapoptotic protein Bax. Cell Death Differ 14: 785-794, 2007
55. Shimizu S, Matsuoka Y, Shinohara Y, Yoneda Y, Tsujimoto Y: Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol 152: 237-250, 2001
56. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD: Voltage-dependent anion channels are dispensable for mitochondrial-depen-dent cell death. Nat Cell Biol 9: 550-555, 2007
57. Pastorino JG, Hoek JB, Shulga N: Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 65: 10545-10554, 2005
58. Shimizu S, Konishi A, Kodama T, Tsujimoto Y: BH4 domain of anti-apoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci USA 97: 3100-3105, 2000
59. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM: Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968, 1997
60. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA, Hardwick JM: Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 274: 21155-21161, 1999
61. Oberbauer R, Schwarz C, Regele HM, Hansmann C, Meyer TW, Mayer G: Regulation of renal tubular cell apoptosis and proliferation after ischemic injury to a solitary kidney. J Lab Clin Med 138: 343-351, 2001
62. Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edel-stein CL: Neutrophil-independent mechanisms of caspase-1-and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 110: 1083-1091, 2002
63. Faubel S, Ljubanovic D, Reznikov L, Somerset H, Dinarello CA, Edel-stein CL: Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int 66: 2202-2213, 2004
64. Dugo L, Collin M, Thiemermann C: Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation. Shock 27: 113-123, 2007
65. Evenson AR, Fareed MU, Menconi MJ, Mitchell JC, Hasselgren PO: GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes. Int J Biochem Cell Biol 37: 2226-2238, 2005
66. Sinha D, Wang Z, Price VR, Schwartz JH, Lieberthal W: Chemical anoxia of tubular cells induces activation of c-Src and its translocation to the zonula adherens. Am J Physiol Renal Physiol 284: F488-F497, 2003
67. Shang T, Joseph J, Hillard CJ, Kalyanaraman B: Death-associated protein kinase as a sensor of mitochondrial membrane potential: Role of lysosome in mitochondrial toxin-induced cell death. J Biol Chem 280: 34644-34653, 2005
68. Doctor RB, Bacallao R, Mandel LJ: Method for recovering ATP content and mitochondrial function after chemical anoxia in renal cell cultures. Am J Physiol 266: C1803-C1811, 1994
69. Ruchalski K, Mao H, Li Z, Wang Z, Gillers S, Wang Y, Mosser DD, Gabai V, Schwartz JH, Borkan SC: Distinct hsp70 domains mediate apopto-sis-inducing factor release and nuclear accumulation. J Biol Chem 281: 7873-7880, 2006
70. Lieberthal W, Fuhro R, Andry CC, Rennke H, Abernathy VE, Koh JS, Valeri R, Levine JS: Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281: F693-F706, 2001
71. Goujon JM, Hauet T, Menet E, Levillain P, Babin P, Carretier M: Histological evaluation of proximal tubule cell injury in isolated perfused pig kidneys exposed to cold ischemia. J Surg Res 82: 228-233, 1999
72. Yin M, Zhong Z, Connor HD, Bunzendahl H, Finn WF, Rusyn I, Li X, Raleigh JA, Mason RP, Thurman RG: Protective effect of glycine on renal injury induced by ischemia-reperfusion in vivo. Am J Physiol Renal Physiol 282: F417-F423, 2002